Target intelligence / Profile preview

Endopeptidase (or Endoproteinase)

Molecular classification
Enzyme, Hydrolase (specifically, a protease subclass)
01

Overview

Endopeptidases (or endoproteases) are a subclass of proteolytic enzymes that cleave internal peptide bonds within protein chains, rather than removing amino acids from the ends[7]. They are critical to the degradation and processing of proteins in biological systems, and play essential roles in digestion, cell signaling, immune responses, cell cycle control, tissue remodeling, and the activation of other proteins (zymogens)[4][2][3][7]. Examples include trypsin, chymotrypsin, and pepsin, each with distinct substrate specificities[7][6]. Dysregulation of endopeptidase activity is implicated in a range of diseases, making them important therapeutic targets and biomarkers[4].\n\nNote: The term "Endoprotease enzyme" is non-specific—there are hundreds of unique enzymes that fit this category. For structured data as required by biomedical informatics, a specific enzyme name (such as "Trypsin" or "HIV-1 protease") would be necessary for proper annotation[5][7][4].

Other names
EndoproteinaseEndopeptidaseProteolytic enzyme (generic)Proteinase
02

Mechanism of action

Competitive inhibition of the active site serine/cysteine/aspartic/metallo group\nAllosteric inhibition\nIrreversible (covalent) inhibition\nZymogen activation blockade

03

Biological functions

Protein catabolismDigestion of dietary proteinsRegulation of cell cycleApoptosisImmune responseSignal transductionActivation of precursors (zymogens)Cellular proliferation, differentiation, and migration
04

Disease associations

CancerInflammatory diseaseNeurodegenerative diseaseCardiovascular diseaseInfectionOther diseases involving dysregulated proteolysis
05

Safety considerations

Off-target proteolysis leading to tissue damageEffects on normal physiological proteolytic cascades (e.g. coagulation, complement)Immune reactions to enzyme therapies or inhibitorsResistance development (in infectious agents)
06

Interacting drugs

Protease inhibitors (such as HIV protease inhibitors: ritonavir, lopinavir; hepatitis C protease inhibitors: boceprevir, telaprevir)

1 more in the full profile.

07

Biomarkers

Protease activity (tissue or plasma, e.g., for cancer prognosis or infection monitoring)Specific enzyme levels (e.g. matrix metalloproteinases in cancer/arthritis)Cleavage products of protease activity

Beyond the preview

Go deeper on Endopeptidase (or Endoproteinase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endopeptidase (or Endoproteinase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call